712356-53-1

Basic information

• Product Name: (1α, 5α, 6α)-6N-(3-azabicyclo [3.1.0] hexyl-3-benzyl)-2-chloro acetamide
• Synonyms: (1α, 5α, 6α)-6N-(3-azabicyclo [3.1.0] hexyl-3-benzyl)-2-chloro acetamide
• CAS NO: 712356-53-1
• Molecular Weight: 264.755
• Mol File: 712356-53-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1α, 5α, 6α)-6N-(3-azabicyclo [3.1.0] hexyl-3-benzyl)-2-chloro acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: (1α, 5α, 6α)-6N-(3-azabicyclo [3.1.0] hexyl-3-benzyl)-2-chloro acetamide(712356-53-1)
• EPA Substance Registry System: (1α, 5α, 6α)-6N-(3-azabicyclo [3.1.0] hexyl-3-benzyl)-2-chloro acetamide(712356-53-1)

Safety Data

• Hazardous Substances Data: 712356-53-1(Hazardous Substances Data)

Upstream product

• 79-04-9 chloroacetyl chloride 
• 151860-17-2 (1α,5α,6α)-3-N-benzyl-6-amino-3-aza-bicyclo[3.1.0]hexane 

Relevant articles and documents

3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS

The invention relates to derivatives of 3,6-disubstituted azabicyclo [3.1.0] hexanes of structure (I). The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.